https://orcid.org/0000-0002-0237-1812
References
- Bassotti G, Usai Satta P, Berti G, et al. Pharmacotherapeutic advances for chronic idiopathic constipation in adults. Expert Opin Pharmacother. 2022;23:2053–2078.
- McCormick D. Managing costs and care for chronic idiopathic constipation. Am J Manag Care. 2019;25(4 Suppl):S63–S69.
- Rao SSC, Brenner DM. Efficacy and safety of over-the-counter therapies for chronic constipation: an updated systematic review. Am J Gastroenterol. 2021;116:1156–1181.
- Ulbricht C, Basch E, Weer W, et al. An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opin Drug Saf. 2006;5:719–728.
- Khan S, Khan SU. Adverse drug event of hypokalaemia-induced cardiotoxicity secondary to the use of laxatives: a systematic review of case reports. J Clin Pharm Ther. 2020;45:927–936.
- Liu Y, Mapa MST, Sprando RL. Anthraquinones inhibit cytochromes P450 enzyme activity in silico and in vitro. J Appl Toxicol. 2021;41:1438–1445.
- Scherf-Clavel O. Drug-drug interactions with over-the-counter medicines: mind the unprescribed. Ther Drug Monit. 2022;44:253–274.
- Ragueneau I, Poirier JM, Radembino N, et al. Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers. Br J Clin Pharmacol. 1999;48:453–456.
- Wang MT, Li IH, Lee WJ, et al. Exposure to sennoside-digoxin interaction and risk of digoxin toxicity: a population-based nested case-control study. Eur J Heart Fail. 2011;13:1238–1243.
- Yoshida H, Takahashi M, Honda M, et al. Co-administration of magnesium oxide reduces the serum concentration of hydrophobic basic drugs in patients treated with antipsychotic drugs. Biol Pharm Bull. 2019;42:1025–1029.
- Visser LE, Penning-van Beest FJ, Wilson JH, et al. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon. Br J Clin Pharmacol. 2004;57:522–524.
- Serrano-Falcón B, Rey E. The safety of available treatments for chronic constipation. Expert Opin Drug Saf. 2017;16:1243–1253.
- Chan TY. Potential risks associated with the use of herbal anti-obesity products. Drug Saf. 2009;32:453–456.
- Pasina L, Novella A, Cortesi L, et al. Drug prescriptions in nursing home residents: an Italian multicenter observational study. Eur J Clin Pharmacol. 2020;76:1011–1019.
- Stevenson JM, Davies JG, Martin FC. Medication-related harm: a geriatric syndrome. Age Ageing. 2019;49:7–11.
- Vich Vila A, Collij V, Sanna S, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020;11:362.